6 research outputs found

    Differential host utilisation by different life history stages of the fish ectoparasite Argulus foliaceus (Crustacea: Branchiura)

    Get PDF
    Contains fulltext : 72168.pdf (publisher's version ) (Open Access

    Search for photons with energies above 1018eV using the hybrid detector of the Pierre Auger Observatory

    Get PDF
    A search for ultra-high energy photons with energies above 1EeV is performed using nine years of data collected by the Pierre Auger Observatory in hybrid operation mode. An unprecedented separation power between photon and hadron primaries is achieved by combining measurements of the longitudinal air-shower development with the particle content at ground measured by the fluorescence and surface detectors, respectively. Only three photon candidates at energies 1\u20132EeV are found, which is compatible with the expected hadron induced background. Upper limits on the integral flux of ultra-high energy photons of 0.027, 0.009, 0.008, 0.008 and 0.007 km 122 sr 121 yr 121 are derived at 95% C.L. for energy thresholds of 1, 2, 3, 5 and 10EeV. These limits bound the fractions of photons in the all-particle integral flux below 0.1%, 0.15%, 0.33%, 0.85% and 2.7%. For the first time the photon fraction at EeV energies is constrained at the sub-percent level. The improved limits are below the flux of diffuse photons predicted by some astrophysical scenarios for cosmogenic photon production. The new results rule-out the early top-down models 12 in which ultra-high energy cosmic rays are produced by, e.g., the decay of super-massive particles 12 and challenge the most recent super-heavy dark matter model

    The future of religious education in Europe

    Get PDF
    This E-book is the result of a workshop on “The future of religious education in Europe”, hosted by the Robert Schuman Centre for Advanced Studies at the European University Institute in Florence on 28 October 2014.This small volume covers the entire conceptual range of approaches to religious education in public schools. The papers gathered in this publication cover the conceptual debate on the subject, ranging from a confessional approach to a sociological approach with an inclusive model as the middle-position. The different models diverge on how they define, in the context of public schooling for children aged 6 to 14 years, what religious education is aimed at: is that what should be conveyed knowledge about religion or instead religious knowledge? Should pupils become cognitively equipped to recognize and discuss religious diversity, or should they first become literate in one, presumably “their own” religious tradition?-- I Kristina Stoeckl – Knowledge about religion and religious knowledge in secular societies: introductory remarks to The future of religious education in Europe -- II Robert Jackson – Inclusive Study of Religions and other Worldviews in Publicly-funded Schools in Democratic Societies -- III Valeria Fabretti – Rethinking Religious Education sociologically: A contribution to the European debate and comparison -- IV Joachim Willems – Religious Education and the Student’s Fundamental Right to Freedom of Religion – Some Lessons and Questions from Germany -- V Matthias Scharer, Innsbruck – “Learning Religion” in the Presence of the Other: Provocation and Gift in Public Educatio

    Clinical, genetic, epidemiologic, evolutionary, and functional delineation of TSPEAR-related autosomal recessive ectodermal dysplasia 14

    No full text

    A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

    No full text
    Many clinical trials have evaluated the benefit of long-term use of antiplatelet drugs in reducing the risk of clinical thrombotic events. Aspirin and ticlopidine have been shown to be effective, but both have potentially serious adverse effects. Clopidogrel, a new thienopyridine derivative similar to ticlopidine, is an inhibitor of platelet aggregation induced by adenosine diphosphate. METHODS: CAPRIE was a randomised, blinded, international trial designed to assess the relative efficacy of clopidogrel (75 mg once daily) and aspirin (325 mg once daily) in reducing the risk of a composite outcome cluster of ischaemic stroke, myocardial infarction, or vascular death; their relative safety was also assessed. The population studied comprised subgroups of patients with atherosclerotic vascular disease manifested as either recent ischaemic stroke, recent myocardial infarction, or symptomatic peripheral arterial disease. Patients were followed for 1 to 3 years. FINDINGS: 19,185 patients, with more than 6300 in each of the clinical subgroups, were recruited over 3 years, with a mean follow-up of 1.91 years. There were 1960 first events included in the outcome cluster on which an intention-to-treat analysis showed that patients treated with clopidogrel had an annual 5.32% risk of ischaemic stroke, myocardial infarction, or vascular death compared with 5.83% with aspirin. These rates reflect a statistically significant (p = 0.043) relative-risk reduction of 8.7% in favour of clopidogrel (95% Cl 0.3-16.5). Corresponding on-treatment analysis yielded a relative-risk reduction of 9.4%. There were no major differences in terms of safety. Reported adverse experiences in the clopidogrel and aspirin groups judged to be severe included rash (0.26% vs 0.10%), diarrhoea (0.23% vs 0.11%), upper gastrointestinal discomfort (0.97% vs 1.22%), intracranial haemorrhage (0.33% vs 0.47%), and gastrointestinal haemorrhage (0.52% vs 0.72%), respectively. There were ten (0.10%) patients in the clopidogrel group with significant reductions in neutrophils (< 1.2 x 10(9)/L) and 16 (0.17%) in the aspirin group. INTERPRETATION: Long-term administration of clopidogrel to patients with atherosclerotic vascular disease is more effective than aspirin in reducing the combined risk of ischaemic stroke, myocardial infarction, or vascular death. The overall safety profile of clopidogrel is at least as good as that of medium-dose aspirin

    Transverse momentum spectra of charged particles in proton-proton collisions at 1as=900 GeV with ALICE at the LHC

    No full text
    The inclusive charged particle transverse momentum distribution is measured in proton-proton collisions at s=900 GeV at the LHC using the ALICE detector. The measurement is performed in the central pseudorapidity region (|\u3b7|<0.8) over the transverse momentum range 0.15<10 GeV/c. The correlation between transverse momentum and particle multiplicity is also studied. Results are presented for inelastic (INEL) and non-single-diffractive (NSD) events. The average transverse momentum for |\u3b7|<0.8 is \u3008pT\u3009INEL=0.483\ub10.001 (stat.)\ub10.007 (syst.) GeV/c and \u3008pT\u3009NSD=0.489\ub10.001 (stat.)\ub10.007 (syst.) GeV/c, respectively. The data exhibit a slightly larger \u3008pT\u3009 than measurements in wider pseudorapidity intervals. The results are compared to simulations with the Monte Carlo event generators PYTHIA and PHOJET. \ua9 2010
    corecore